Literature DB >> 2591733

Genetic studies on an Alzheimer clinic population.

A D Sadovnick1, M E Irwin, P A Baird, B L Beattie.   

Abstract

All patients attending the Clinic for Alzheimer Disease and Related Disorders have detailed family histories taken by a geneticist. To date, genetic histories are available for 446 consecutive, unrelated individuals. Of these, 151 (33.9%) are diagnosed as having "probable" (N = 141) or "autopsy-confirmed" (N = 10) Alzheimer disease according to recognized criteria. This data base represents a relatively unselected population with respect to more than one person in the family having dementia. Seventy-one of these 151 index cases (47.0%) have a positive family history of dementia, of which 8 (5.3%) may represent the familial (autosomal dominant) form of Alzheimer disease (FAD). Age-corrected empiric recurrence risks for Alzheimer disease/dementia were calculated for first-degree relatives of these 151 index cases using the Kaplan-Meier lifetable method.

Entities:  

Mesh:

Year:  1989        PMID: 2591733     DOI: 10.1002/gepi.1370060508

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  5 in total

1.  Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews.

Authors:  H Yang; C McElree; M P Roth; F Shanahan; S R Targan; J I Rotter
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

2.  Genetic factors that protect against dementia.

Authors:  C Hirst; I M Yee; A D Sadovnick
Journal:  Am J Hum Genet       Date:  1994-09       Impact factor: 11.025

Review 3.  Genomic variants, genes, and pathways of Alzheimer's disease: An overview.

Authors:  Adam C Naj; Gerard D Schellenberg
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

4.  Estimating the probability for major gene Alzheimer disease.

Authors:  L A Farrer; L A Cupples
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

5.  Beyond proof of principle: new genes for Alzheimer's disease through collaboration.

Authors:  Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Lancet Neurol       Date:  2009-11       Impact factor: 44.182

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.